SCHEMBL17273620

SCHEMBL17273620

CC(C)(C)NC(=O)C(O)c1ccc(Br)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.41
NPC1 O15118 5/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALPL P05186 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
B3GNT2 Q9NY97 1/20 0.36
LMNA P02545 1/20 0.36
S1PR4 O95977 3/20 0.36
S1PR3 Q99500 3/20 0.36
S1PR2 O95136 2/20 0.36
FDPS P14324 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
MAPK1 P28482 2/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9649808 0.81 ADRB2 (0.37) RAB9ANPC1ALDH1A1KDM4ETP53
SCHEMBL21355063 0.73 RAB9A (0.37) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL13388549 0.72 ALDH1A1 (0.55) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL17273622 0.72 HIF1A (0.50) KMT2ALMNACYP1A2CYP2C9TSHR
SCHEMBL2099345 0.71 KDM4E (0.41) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL12940584 0.71 B3GNT2 (0.47) MEN1KMT2AALDH1A1KDM4EB3GNT2
SCHEMBL1577349 0.70 KDM4E (0.41) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL2148491 0.70 KDM4E (0.41) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4901266 0.70 KDM4E (0.41) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL31241015 0.70 RAB9A (0.58) RAB9ANPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940024-B1 BENZOXAZINE OXAZOLIDINONE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2018-12-05 EP disclosed
US-9416144-B2 Benzoxazine oxazolidinone compound, preparation method and application thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-08-16 US disclosed
US-20150336984-A1 BENZOXAZINE OXAZOLIDINONE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2015-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336984-A1 BENZOXAZINE OXAZOLIDINONE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF OXA1L, XDH, MYD88 RAB9A 3162/4885NPC1 1350/4885MEN1 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.